causal

Me-Too Drugs Are Molecular Tweaks for New Patents

Companies take top-selling drugs originally discovered in publicly funded labs, 'twiddle a molecule' enough to obtain a new patent and exclusive marketing rights, and market the result as a new drug, producing whole classes of 'me-too' drugs with no demonstrable difference between them.

causalpending

Speaker

Marcia Angell

Evidence Quote

“these were called 'me-too' drugs. It's a shower of drugs, all in the same class with no real difference that anyone can put their finger on. And that's what they do. They turn out one of these after the other.”

Source

Marcia Angell on Big Pharma— EconTalk
Created: 6/13/2026, 12:08:22 AM

Your notes

Loading notes...